About
Graphite Bio is a clinical-stage biotechnology company developing gene editing therapies using CRISPR technology to treat serious genetic diseases.
Explore Graphite Bio's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.